Blog
Is H. B. Fuller (FUL) Stock Undervalued Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Why Maplebear (CART) is a Top Value Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Is Genesco (GCO) Stock Outpacing Its Retail-Wholesale Peers This Year?
The Retail-Wholesale group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Genesco (GCO) is a stock that can certainly grab the
Is Bioventus (BVS) Stock Outpacing Its Medical Peers This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Bioventus (BVS) one of those stocks right now? Let's take a
Here's Why American Eagle Outfitters (AEO) is a Strong Value Stock
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
Featuring daily updates
Should Value Investors Buy Crown Holdings (CCK) Stock?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always
Is KBR (KBR) a Great Value Stock Right Now?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Here's Why Best Buy (BBY) is a Strong Value Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Are Consumer Discretionary Stocks Lagging Cimpress (CMPR) This Year?
The Consumer Discretionary group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Cimpress (CMPR) been one of those stocks
Should Value Investors Buy RENAULT (RNLSY) Stock?
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always
Bank of Marin (BMRC) Q2 Earnings and Revenues Top Estimates
Bank of Marin (BMRC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.29 per share a year ago. These
How Much Are Pricing Gains Boosting Mission Produce's Results?
Mission Produce, Inc. AVO has been navigating a highly volatile avocado market, where pricing swings often have a significant impact on financial performance. While lower avocado prices weighed on
Kinsale Capital Group, Inc. (KNSL) Recently Broke Out Above the 20-Day Moving Average
Kinsale Capital Group, Inc. (KNSL) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, KNSL crossed above the 20-day moving
Brokers Suggest Investing in Constellation Energy Corporation (CEG): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is Celsius (CELH) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Wall Street Analysts Think Comfort Systems (FIX) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Bulls Look Optimistic About Datadog (DDOG): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Brokers Suggest Investing in Arista Networks (ANET): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is McKesson (MCK) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Is Cloudflare (NET) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Compared to Estimates, Bank of Hawaii (BOH) Q2 Earnings: A Look at Key Metrics
Bank of Hawaii (BOH) reported $196.9 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 12.9%. EPS of $1.47 for the same period compares to $1.06 a year
Compared to Estimates, Sierra Bancorp (BSRR) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2026, Sierra Bancorp (BSRR) reported revenue of $38.98 million, down 0.6% over the same period last year. EPS came in at $0.77, compared to $0.78 in the year-ago quarter.
Hope Bancorp (HOPE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Hope Bancorp (HOPE) reported $147.82 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 10.8%. EPS of $0.27 for the same period compares to $0.19 a year
Here's What Key Metrics Tell Us About Ensign Group (ENSG) Q2 Earnings
Ensign Group (ENSG) reported $1.44 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 17.3%. EPS of $1.92 for the same period compares to $1.59 a year ago.
Astrazeneca (AZN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Astrazeneca (AZN) reported $15.38 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 6.4%. EPS of $2.63 for the same period compares to $2.18 a year ago.


